Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia (ITP)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04890041
What this trial is testing

TPO-RA in Primary Immune Thrombocytopenia (ITP) in Patients Older Than 14 Years

Who this might be right for
Primary Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Testing effectiveness (Phase 2)Study completedNCT03838354
What this trial is testing

A Clinical Trial of Chidamide in the Management of Refractory ITP

Who this might be right for
Thrombocytopenia
Shandong University 61
Large-scale testing (Phase 3)WithdrawnNCT05046327
What this trial is testing

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc.
Large-scale testing (Phase 3)Study completedNCT03010202
What this trial is testing

The PROLONG Trial - Rituximab Maintenance Therapy in ITP

Who this might be right for
Purpura, Thrombocytopenic, Idiopathic
Ostfold Hospital Trust 136
Testing effectiveness (Phase 2)Study completedNCT01965626
What this trial is testing

Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP

Who this might be right for
Thrombocytopenia
Shandong University 96
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006
What this trial is testing

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

Who this might be right for
Thrombocytopenia, Immune
Qilu Pharmaceutical Co., Ltd. 60
Large-scale testing (Phase 3)Looking for participantsNCT07700238
What this trial is testing

Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Amgen 126
Testing effectiveness (Phase 2)Looking for participantsNCT04993885
What this trial is testing

Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

Who this might be right for
Immune ThrombocytopeniaAutoantibodiesEvan Syndrome+1 more
Institute of Hematology & Blood Diseases Hospital, China 52
Large-scale testing (Phase 3)Not Yet RecruitingNCT07051915
What this trial is testing

The Holistic Study

Who this might be right for
Thrombocytopenia Purpura
Ostfold Hospital Trust 220
Not applicableStudy completedNCT06071520
What this trial is testing

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

Who this might be right for
Primary Immune Thrombocytopenia
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 50
Post-approval studies (Phase 4)Looking for participantsNCT07788456
What this trial is testing

Multi-target Drugs Sequential Combination Therapy in Adults Patients With Newly Diagnosed Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 38
Large-scale testing (Phase 3)Study completedNCT03939637
What this trial is testing

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 122
Large-scale testing (Phase 3)UnknownNCT02627417
What this trial is testing

Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia

Who this might be right for
Adult Immune Thrombocytopenia (ITP)Dapsone
Assistance Publique - Hôpitaux de Paris 216
Testing effectiveness (Phase 2)Study completedNCT02153060
What this trial is testing

An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Shandong University 58
Large-scale testing (Phase 3)Study completedNCT04516967
What this trial is testing

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Who this might be right for
Immune Thrombocytopenia
Sobi, Inc. 75
Large-scale testing (Phase 3)Looking for participantsNCT07233213
What this trial is testing

An Open-label Study of Intravenous Immunoglobulin (5%) for the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Grand Shuyang Life Sciences (Chengdu) Co., Ltd. 36
Not applicableUnknownNCT03975361
What this trial is testing

Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE)

Who this might be right for
Immune Thrombocytopenia (ITP)Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 10
Testing effectiveness (Phase 2)UnknownNCT03033199
What this trial is testing

Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University 60
Not applicableUnknownNCT04949009
What this trial is testing

Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

Who this might be right for
Primary Immune Thrombocytopenia
Shandong University 400
Testing effectiveness (Phase 2)Study completedNCT01667263
What this trial is testing

The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
Autoimmune Thrombocytopenia
Peking University People's Hospital 130
Next Page